Mission
TO DRIVE A NEW ERA OF DISCOVERY IN DISEASE ORIENTED SCIENCE AND TO MENTOR TOMORROW'S LEADERS IN AN INSPIRING AND DIVERSE ENVIRONMENT.
Public Charity
THE J DAVID GLADSTONE INSTITUTES
THE J DAVID GLADSTONE INSTITUTES, of SAN FRANCISCO, CA, is a Public Charity tracked in Imperigo's IRS 990 database. The 2024 filing shows $119.2M in revenue, $144.8M in expenses, $372.0M in total assets. 205 publicly reported grants to this organization, totaling roughly $146.7M, appear in IRS filings.
EIN: 237203666
SAN FRANCISCO, CA
Medical Disciplines Research
NTEE: H90
Latest filing: 2024
Total Revenue$119.2M
Total Expenses$144.8M
Total Assets$372.0M
Grant Records205
Funding Total$146.7M
Filing Years2019–2024
Where $100 goes at The J David Gladstone Institutes
How The J David Gladstone Institutes divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
$84
Programs
the work itself
$14
Management
running the organization
$2
Fundraising
raising the next dollar
Inside the $84 for programs
$30
The institute of neurological disease maintains a strong focus on neurodegenerative and neuroinflammatory diseases, including alzheimer's disease and other dementias, parkinson's disease, amyotrophic lateral sclerosis (als), and multiple…
$20
The gladstone institute of data science and biotechnology invests in talent to create new ways to analyze and integrate datasets, including machine learning approaches that leverage the rapid…
$18
The institute of virology has made significant contributions to fight HIV/AIDS, sars-cov-2, hepatitis c, zika, and cytomegalovirus infections leading to global and groundbreaking efforts in HIV prevention and…
Plus 1 more program. Cost per person served and the full program breakdown are on the full profile.
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
RESEARCH GRANTS
$320,000
CMT RESEARCH
$300,000
DECODING PROTEIN TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER TO ENABLE NEW ALZHEIMER'S THERAPIES (CFSF SUPPLEMENT)
$258,615
DEVELOPING CELL-TYPE-SPECIFIC ENHANCER-AAV VECTORS TO CHARACTERIZE AND RESTORE AB- AND TAU-DEPENDENT CIRCUIT AND COGNITIVE DEFICITS IN HUMANIZED ALZHEIMER'S MOUSE MODELS (CFSF SUPPLEMENT)
$258,573
DEVELOPING CELL-TYPE-SPECIFIC ENHANCER-AAV VECTORS TO CHARACTERIZE AND RESTORE AB- AND TAU-DEPENDENT CIRCUIT AND COGNITIVE DEFICITS IN HUMANIZED ALZHEIMER'S MOUSE MODEL
$201,250
Showing up to 5 of 205 total records — full history available with membership.
Officers & Directors
DIRECTOR
Alex Marson
TRUSTEE
Andrew S Garb
DIRECTOR
Benoit Bruneau
PRESIDENT
Deepak Srivastava
VP OF PEOPLE SERVICES
Jennifer Crosby
SR. INVESTIGATOR
Katerina Akassoglou
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $119.2M | $144.8M | $372.0M |
| 2023 | $119.2M | $127.7M | $365.3M |
| 2022 | $144.8M | $119.0M | $358.3M |
| 2020 | $84.3M | $93.5M | $318.4M |
| 2019 | $62.8M | $82.3M | $314.2M |
Between 2019 and 2024, reported annual revenue grew from $62.8M to $119.2M (+90%), with total assets most recently reported at $372.0M.
Interactive year-over-year charts and full filing details available with membership.